Superworth

Conexeu Sciences CNXU

Medical - Instruments & Supplies, Healthcare
$2.40
−5.51%
Market cap
$67.7M
PE
n/m
one or more of the four quarters through 2026-07-31 missing
Forward PE
n/m
not a meaningful number
Price to sales
n/m
not a meaningful number
EV/EBIT
n/m
not a meaningful number
Revenue, 12 months
n/m
not a meaningful number
Net margin
n/m
not a meaningful number
Free cash flow yield
n/m
not a meaningful number

Charts

Financials

Income statement for CNXU, by quarter
Income statementQ1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
R&D$23.7K$42.5K$134.7K$62.6K$66.6K$270.4K
SG&A$8.5K$25K$22.6K$18.4K$26.1K$140.6K
−$333.5K−$457K−$1.3M−$1.7M−$2.4M−$7.7M
Interest expense$3.6K$1.4K−$43$0$0$0
Pre-tax income−$290.1K−$458.1K−$1.3M−$1.7M−$2.3M−$7.7M
$0$0$0$0$0$0
Net income−$290.1K−$458.1K−$1.3M−$1.7M−$2.3M−$7.7M
−$0.03−$0.05−$0.09−$0.08−$0.11−$0.29
8.9M9.5M14.1M20.6M20.6M27M

R&D: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

SG&A: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

Operating income: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

Interest expense: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

Pre-tax income: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

Income tax: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

Net income: Q1 FY25 and Q1 FY26: 6 months less the 3 months printed beside them.

EPS, diluted: Q1 FY25 and Q1 FY26: quarter's net income to common over its shares, to the cent.

Diluted shares: Q1 FY25 and Q1 FY26: share-days: the 6-month average less the second quarter's.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest Conexeu Sciences' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
CNXUConexeu Sciences$67.7Mn/mn/an/mn/mn/m
APTAlpha Pro Tech$56.3M13.5×14.8×0.9×+6%6.8%
KEQUKewaunee Scientific$96.7M12.1×13.6×0.3×+5%3.0%
NEPHNephros$35.2M20.3×28.3×1.7×+24%8.4%
PDEXPro DEX$184.5M15.9×16.5×2.3×+13%15.1%
UTMDUtah Medical Products$224.6M21.5×20.9×6.2×−7%29.0%
INFUInfuSystem$275.7M33.8×43.5×1.9×+2%6.0%
EMBCEmbecta$350.7M4.2×11.6×0.3×−8%8.6%
TCMDTactile Systems Technology$518.1M21.2×62.3×1.5×+17%7.1%
Peer median$204.5M18.1×18.7×1.6×+6%7.7%

More on Conexeu Sciences

Each number over time

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .